Showing 1 - 20 results of 25 for search 'Michael J Sorich', query time: 0.07s Refine Results
  1. 1
    Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver Disease

    Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver Disease by Lauren A. Newman, Michael J. Sorich, Andrew Rowland

    Published 2020-06-01
    Get full text
    Article
  2. 2
    Indirect estimation of the comparative treatment effect in pharmacogenomic subgroups.

    Indirect estimation of the comparative treatment effect in pharmacogenomic subgroups. by Michael J Sorich, Michael Coory, Brita A K Pekarsky

    Published 2013-01-01
    Get full text
    Article
  3. 3
    Mechanistic Modelling Identifies and Addresses the Risks of Empiric Concentration-Guided Sorafenib Dosing

    Mechanistic Modelling Identifies and Addresses the Risks of Empiric Concentration-Guided Sorafenib Dosing by Warit Ruanglertboon, Michael J. Sorich, Ashley M. Hopkins, Andrew Rowland

    Published 2021-04-01
    Get full text
    Article
  4. 4
    Predictors of anti-VEGF drug-induced hypertension using different hypertension criteria: a secondary analysis of the COMPARZ study

    Predictors of anti-VEGF drug-induced hypertension using different hypertension criteria: a secondary analysis of the COMPARZ study by Arduino A. Mangoni, Ganessan Kichenadasse, Andrew Rowland, Michael J. Sorich

    Published 2018-02-01
    Get full text
    Article
  5. 5
    Predictors of Long-Term Disease Control and Survival for HER2-Positive Advanced Breast Cancer Patients Treated With Pertuzumab, Trastuzumab, and Docetaxel

    Predictors of Long-Term Disease Control and Survival for HER2-Positive Advanced Breast Cancer Patients Treated With Pertuzumab, Trastuzumab, and Docetaxel by Ashley M. Hopkins, Andrew Rowland, Ross A. McKinnon, Michael J. Sorich

    Published 2019-08-01
    Get full text
    Article
  6. 6
    Risk Factors for Severe Diarrhea with an Afatinib Treatment of Non-Small Cell Lung Cancer: A Pooled Analysis of Clinical Trials

    Risk Factors for Severe Diarrhea with an Afatinib Treatment of Non-Small Cell Lung Cancer: A Pooled Analysis of Clinical Trials by Ashley M. Hopkins, Anh-Minh Nguyen, Christos S. Karapetis, Andrew Rowland, Michael J. Sorich

    Published 2018-10-01
    Get full text
    Article
  7. 7
    Use of Multiprognostic Index Domain Scores, Clinical Data, and Machine Learning to Improve 12-Month Mortality Risk Prediction in Older Hospitalized Patients: Prospective Cohort Study

    Use of Multiprognostic Index Domain Scores, Clinical Data, and Machine Learning to Improve 12-Month Mortality Risk Prediction in Older Hospitalized Patients: Prospective Cohort Stu... by Richard John Woodman, Kimberley Bryant, Michael J Sorich, Alberto Pilotto, Arduino Aleksander Mangoni

    Published 2021-06-01
    Get full text
    Article
  8. 8
    Prognostic Associations of Concomitant Antibiotic Use in Patients with Advanced NSCLC Treated with Atezolizumab: Sensitivity Analysis of a Pooled Investigation of Five Randomised Control Trials

    Prognostic Associations of Concomitant Antibiotic Use in Patients with Advanced NSCLC Treated with Atezolizumab: Sensitivity Analysis of a Pooled Investigation of Five Randomised C... by Arkady T Manning-Bennett, Julie Cervesi, Pierre-Alain Bandinelli, Michael J Sorich, Ashley M Hopkins

    Published 2023-02-01
    Get full text
    Article
  9. 9
    Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease

    Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease by Lauren A. Newman, Zivile Useckaite, Jillian Johnson, Michael J. Sorich, Ashley M. Hopkins, Andrew Rowland

    Published 2022-01-01
    Get full text
    Article
  10. 10
    Importance of between and within Subject Variability in Extracellular Vesicle Abundance and Cargo when Performing Biomarker Analyses

    Importance of between and within Subject Variability in Extracellular Vesicle Abundance and Cargo when Performing Biomarker Analyses by Lauren A. Newman, Alia Fahmy, Michael J. Sorich, Oliver G. Best, Andrew Rowland, Zivile Useckaite

    Published 2021-02-01
    Get full text
    Article
  11. 11
    Reply to Auclin et al. Comment on “Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. <i>Cancers</i> 2021, <i>13</i>, 1176”

    Reply to Auclin et al. Comment on “Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combinati... by Ashley M. Hopkins, Ganessan Kichenadasse, Ahmad Y. Abuhelwa, Ross A. McKinnon, Andrew Rowland, Michael J. Sorich

    Published 2021-07-01
    Get full text
    Article
  12. 12
    Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial

    Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Tr... by Ashley M. Hopkins, Ganessan Kichenadasse, Ahmad Y. Abuhelwa, Ross A. McKinnon, Andrew Rowland, Michael J. Sorich

    Published 2021-03-01
    Get full text
    Article
  13. 13
    Machine Learning for Prediction of Survival Outcomes with Immune-Checkpoint Inhibitors in Urothelial Cancer

    Machine Learning for Prediction of Survival Outcomes with Immune-Checkpoint Inhibitors in Urothelial Cancer by Ahmad Y. Abuhelwa, Ganessan Kichenadasse, Ross A. McKinnon, Andrew Rowland, Ashley M. Hopkins, Michael J. Sorich

    Published 2021-04-01
    Get full text
    Article
  14. 14
    Commentary: Association Between Antihypertensive Medication Use and Breast Cancer: A Systematic Review and Meta-Analysis

    Commentary: Association Between Antihypertensive Medication Use and Breast Cancer: A Systematic Review and Meta-Analysis by Natansh D. Modi, Ahmad Y. Abuhelwa, Bradley D. Menz, Ross A. McKinnon, Michael J. Sorich, Ashley M. Hopkins

    Published 2021-08-01
    Get full text
    Article
  15. 15
    Targeted pharmacotherapy after somatic cancer mutation screening [version 2; referees: 2 approved]

    Targeted pharmacotherapy after somatic cancer mutation screening [version 2; referees: 2 approved] by Thomas M. Polasek, Karen Ambler, Hamish S. Scott, Michael J. Sorich, Peter A. Kaub, Andrew Rowland, Michael D. Wiese, Ganessan Kichenadasse

    Published 2016-09-01
    Get full text
    Article
  16. 16
    C-reactive protein provides superior prognostic accuracy than the IMDC risk model in renal cell carcinoma treated with Atezolizumab/Bevacizumab

    C-reactive protein provides superior prognostic accuracy than the IMDC risk model in renal cell carcinoma treated with Atezolizumab/Bevacizumab by Ahmad Y. Abuhelwa, Joaquim Bellmunt, Ganessan Kichenadasse, Ganessan Kichenadasse, Ross A. McKinnon, Andrew Rowland, Michael J. Sorich, Ashley M. Hopkins

    Published 2022-08-01
    Get full text
    Article
  17. 17
    Nuances to precision dosing strategies of targeted cancer medicines

    Nuances to precision dosing strategies of targeted cancer medicines by Ashley M. Hopkins, Bradley D. Menz, Michael D. Wiese, Ganessan Kichenadasse, Howard Gurney, Ross A. McKinnon, Andrew Rowland, Michael J. Sorich

    Published 2020-08-01
    Get full text
    Article
  18. 18
    The association of depression and anxiety with treatment outcomes in patients with rheumatoid arthritis – a pooled analysis of five randomised controlled trials

    The association of depression and anxiety with treatment outcomes in patients with rheumatoid arthritis – a pooled analysis of five randomised controlled trials by Arkady T. Manning-Bennett, Ashley M. Hopkins, Michael J. Sorich, Susanna M. Proudman, David J.R. Foster, Ahmad Y. Abuhelwa, Michael D. Wiese

    Published 2022-07-01
    Get full text
    Article
  19. 19
    A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials

    A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials by Lee X. Li, Mark A. Socinski, Ganessan Kichenadasse, Christos S. Karapetis, Adel Shahnam, Ross A. McKinnon, Andrew Rowland, Ashley M. Hopkins, Michael J. Sorich

    Published 2024-03-01
    Get full text
    Article
  20. 20
    Prediction of severe neutropenia and diarrhoea in breast cancer patients treated with abemaciclib

    Prediction of severe neutropenia and diarrhoea in breast cancer patients treated with abemaciclib by Natansh D. Modi, Ahmad Y. Abuhelwa, Sarah Badaoui, Emily Shaw, Kiran Shankaran, Ross A. McKinnon, Andrew Rowland, Michael J. Sorich, Ashley M. Hopkins

    Published 2021-08-01
    Get full text
    Article

Search Tools: